William Cash
- SOM: Peds: Solid Tumor
Associate Professor
-
Aflac Cancer & Blood Disorders Center
1760 Haygood Drive NE
Academic Appointment
- Associate Professor of Pediatrics, Emory University
Education
Degrees
- MSc from Emory University
- MD from University of Alabama
- BS from Auburn University
Research
Publications
-
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE.
Pediatr Blood Cancer Volume: 72 Page(s): e31419
01/01/2025 Authors: Bryan G; Guolla L; Villanueva GI; Cohen-Gogo S; Casanovas A; Medina R; Revon-Riviere G; Coltin H; Kahalley LS; Withycombe JS -
Trends in analgesia-sedation of pediatric patients receiving I-131 MIBG in the pediatric intensive care unit: A report from the Pediatric Health Information System database.
Pediatr Blood Cancer Volume: 71 Page(s): e31205
10/01/2024 Authors: Dhuse J; Cash T; Elges MS; Alazraki A; Beer R; Jergel A; Goldsmith KC; Hall M; Kamat PP -
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.
Volume: 41 Page(s): 4724 - 4728
10/20/2023 Authors: Cash T; Krailo MD; Buxton AB; Pawel BR; Healey JH; Binitie O; Marcus KJ; Grier HE; Grohar PJ; Reed DR -
Children's Oncology Group's 2023 blueprint for research: Young investigators.
Pediatr Blood Cancer Volume: 70 Suppl 6 Page(s): e30567
09/01/2023 Authors: Esbenshade AJ; Kahalley LS; Wistinghausen B; Cash T; Baertschiger RM; Zarnegar-Lumley S; Green A; Dhall G; COG Young Investigators Committee -
A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
Volume: 70 Page(s): e30405
08/01/2023 Authors: Cash T; Jonus HC; Tsvetkova M; Beumer JH; Sadanand A; Lee JY; Henry CJ; Aguilera D; Harvey RD; Goldsmith KC -
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor.
J Clin Oncol Volume: 41 Page(s): 508 - 516
01/20/2023 Authors: Lerman BJ; Li Y; Carlowicz C; Granger M; Cash T; Sadanand A; Somers K; Ranavaya A; Weiss BD; Choe M -
Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia.
Cancer Volume: 128 Page(s): 4129 - 4138
12/01/2022 Authors: Patel PA; DeGroote NP; Jackson K; Cash T; Castellino SM; Jaggi P; Esbenshade AJ; Miller TP -
A PHASE I STUDY OF NAB-PACLITAXEL COMBINED WITH GEMCITABINE FOR PEDIATRIC RELAPSED/REFRACTORY SOLID TUMORS
Volume: 69 Page(s): S319 - S320
11/01/2022 Authors: Metts J; Ginn K; Cost C; Froug B; Watt A; Schink M; Senn S; Cash T -
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
Neuro Oncol Volume: 24 Page(s): 1776 - 1789
10/03/2022 Authors: Desai AV; Robinson GW; Gauvain K; Basu EM; Macy ME; Maese L; Whipple NS; Sabnis AJ; Foster JH; Shusterman S -
A bridge over troubled water-Extending induction for high-risk neuroblastoma patients with poor end-of-induction response.
Cancer Volume: 128 Page(s): 2880 - 2882
08/01/2022 Authors: Federico SM; Cash T